Ask anyone who works in the research department of a large pharmaceutical company tasked with developing drugs based on papers published by academic scientists.
Those who supply this information include Cancer Research UK (the most important research organisation), the Department of Health, Wellcome Trust and the Association of the British Pharmaceutical Industry.
But another study, by researchers at the department of Veterans Affairs, puts the focus on a far older class of drugs, which are the pharmaceutical industry's perennial bestsellers for stopping another killer, heart disease--statins.